Your browser doesn't support javascript.
loading
Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial.
Ailani, Jessica; McAllister, Peter; Winner, Paul K; Chakhava, George; Krog Josiassen, Mette; Lindsten, Annika; Sperling, Bjørn; Ettrup, Anders; Cady, Roger.
Affiliation
  • Ailani J; Department of Neurology, Georgetown University Hospital, Washington, DC, USA.
  • McAllister P; New England Institute for Neurology and Headache, Stamford, CT, USA.
  • Winner PK; Palm Beach Headache Center, West Palm Beach, FL, USA.
  • Chakhava G; Georgian Association of Medical Specialties, Multiprofile Clinic Consilium Medulla, D.Tvildiani Medical University, Tbilisi, Georgia.
  • Krog Josiassen M; H. Lundbeck A/S, Copenhagen, Denmark.
  • Lindsten A; H. Lundbeck A/S, Copenhagen, Denmark.
  • Sperling B; H. Lundbeck A/S, Copenhagen, Denmark.
  • Ettrup A; H. Lundbeck A/S, Copenhagen, Denmark.
  • Cady R; Lundbeck LLC, Deerfield, IL, USA. rcady@rkconsults.com.
BMC Neurol ; 22(1): 205, 2022 Jun 03.
Article in En | MEDLINE | ID: mdl-35659622
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Photophobia / Migraine Disorders Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies Limits: Adult / Humans Language: En Journal: BMC Neurol Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Photophobia / Migraine Disorders Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies Limits: Adult / Humans Language: En Journal: BMC Neurol Year: 2022 Document type: Article